Replimune Group, Inc. (REPL)
7.76
+0.50
(+6.89%)
USD |
NASDAQ |
Jan 22, 12:00
Replimune Group Price: 7.76 for Jan. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Rapt Therapeutics, Inc. | 57.66 |
| Olema Pharmaceuticals, Inc. | 27.03 |
| CorMedix, Inc. | 7.52 |
| Verastem, Inc. | 6.72 |
| Anavex Life Sciences Corp. | 5.24 |
Price Related Metrics
| PEG Ratio | -0.1364 |
| Price to Book Value | 2.312 |
| Earnings Yield | -46.49% |
| Market Cap | 608.72M |
| PEGY Ratio | -0.1364 |